is inviting stakeholders to have their say on the future of specialised health services.
Specialised services, those provided from a smaller number of specialist centres rather than in every hospital, include medical genetics and rare disease services, including inherited conditions and others with significant genetic components, such as certain rare cancers.
These services are largely (but not wholly) commissioned on a national (rather than local) basis by the NHS Specialised Services
and collectively account for around 10% of the NHS budget already, with rising demand. Clinical Commissioning Groups and local authorities are also responsible for commissioning parts of care pathways, and delivering some of the care for patients within specialised services. This can result in variable care being experienced by patients depending on where they live, an undesirable ‘postcode lottery’ effect.
Now NHS England is inviting patients, patient groups, commissioners, clinicians and other stakeholders to an event on 9th December to inform the future development of give their views on the future of specialised health services and their provision.
Clinical Director for Specialised Services James Palmer explained that they hoped findings would “drive forward the promotion of equity and excellence in the commissioning of specialised services, and ensure that patients receive high quality, integrated care, regardless of where they live”.
Places are limited at the stakeholder event, but there will apparently be scope for others to provide written contributions to the consultation and strategy development process.